← Open Payments lookup

DANIEL VERINA: Open Payments

NPI 1083929897 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$73,535 in 155 payments from 12 companies in 2025. Trend: 2023 $84,740 · 2024 $115,593 · 2025 $73,535

Speaker / faculty: $55,874Travel & lodging: $11,372Food & beverage: $4,897Grant: $1,000Honoraria: $230Education: $100
CompanyPaymentsAmount
Janssen Biotech, Inc.91$65,667
GENZYME CORPORATION12$3,108
GlaxoSmithKline, LLC.9$1,556
PFIZER INC.7$1,529
Karyopharm Therapeutics Inc.17$590
Legend Biotech USA Inc.5$329
Adaptive Biotechnologies Corporation6$249
Kite Pharma, Inc.2$230
Janssen Scientific Affairs, LLC1$134
Takeda Pharmaceuticals U.S.A., Inc.3$89

Products named: RYBREVANT, SARCLISA, ELREXFIO, XPOVIO, TECVAYLI, DARZALEX, CARVYKTI, clonoSEQ.

Industry payments across NY — which companies pay providers there.